STEAP4 and hepatocellular carcinoma: Overall and disease-free Kaplan-Meier analysis showed that patients with low STEAP4 expression had shorter survival time than patients with high STEAP4 expression (Fig. 1b), suggesting STEAP4 might be negatively associated with HCC progression.